Abstract
The ability to non-invasively monitor DNA oxidation and its repair has significant utility in large-scale, population-based studies. Such studies could include assessments of the efficacy of antioxidant intervention strategies, pathological roles of DNA oxidation in various disease states and population or inter-individual differences in antioxidant defence and DNA repair. The analysis of urine, or indeed any extracellular matrix, for 8-oxo-7,8-dihydro-2ʹ-deoxyguanosine (8-oxodG), using chromatographic or immunoassay procedures, is by far the most popular method to non-invasively assess oxidative insult to the genome. The actual biological significance of the presence of extracellular 8-oxodG is still a subject for debate however. Studies are slowly ruling out confounding factors such as diet and cell turnover, which would leave endogenous processes, notably repair, as the sole source of extracellular 8-oxodG. The method described herein exploits the non-invasive properties of urine sampling, coupled with efficient extraction of 8-oxodG by a validated solid-phase extraction procedure. Subsequent analysis by liquid chromatography–tandem mass spectrometry has the advantages of sensitivity, internal standardisation and robust peak identification.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Kasai, H. (1997) Analysis of a form of oxidative DNA damage, 8-hydroxy-2’-deoxyguanosine, as a marker of cellular oxidative stress during carcinogenesis. Mutat. Res. 387, 147–163.
Bogdanov, M.B., Beal, M.F., McCabe, D.R., Griffin, R.M., and Matson, W.R. (1999) A carbon column-based liquid chromatography electrochemical approach to routine 8-hydroxy-2’-deoxyguanosine measurements in urine and other biologic matrices: A one-year evaluation of methods. Free Radic. Biol. Med. 27, 647–666.
Wu, L.L., Chiou, C.-C., Chang, P.-Y., and Wu, J.T. (2004) Urinary 8-OHdG: a marker of oxidative stress to DNA and a risk factor for cancer, atherosclerosis and diabetics. Clin. Chim. Acta 339, 1–9.
Cooke, M.S., Evans, M.D., Dove, R., Rozalski, R., Gackowski, D., Siomek, A., Lunec, J., and Olinski, R. (2005) DNA repair is responsible for the presence of oxidatively damaged DNA lesions in urine. Mutat. Res. 574, 58–66.
Siomek, A., Tujakowski, J., Gackowski, D., Rozalski, R., Foksinski, M., Dziaman, T., Roszkowski, K., and Olinski, R. (2006) Severe oxidatively damaged DNA after cisplatin treatment of cancer patients. Int. J. Cancer 119, 2228–2230.
Cooke, M.S., Lunec, J., and Evans, M.D. (2002) Progress in the analysis of urinary oxidative DNA damage. Free Radic. Biol. Med. 33, 1601–1614.
Haghdoost, S., Sjolander, L., Czene, S., and Harms-Ringdahl, M. (2006) The nucleotide pool is a significant target for oxidative stress. Free Radic. Biol. Med. 41, 620–626.
Bogdanov, M.B., Beal, M.F., McCabe, D.R., Griffin, R.M., and Matson, W.R. (1999) A carbon column-based liquid chromatography electrochemical approach to routine 8-hydroxy-2’-deoxyguanosine measurements in urine and other biologic matrices: A one-year evaluation of methods. Free Radic. Biol. Med. 27, 647–666.
Rozalski, R., Siomek, A., Gackowski, D., Foksinski, M., Gran, C., Klungland, A., and Olinski, R. (2004) Diet is not responsible for the presence of several oxidatively damaged DNA lesions in mouse urine. Free Radic. Res. 11, 1201–1205.
Ravanat, J.L., Guicherd, P., Tuce, Z., and Cadet, J. (1999) Simultaneous determination of five oxidative DNA lesions in human urine. Chem. Res. Toxicol. 12, 802–808.
Hu, C.W., Wang, C.J., Chang, L.W., and Chao, M.R. (2006) Clinical-scale high-throughput analysis of urinary 8-oxo-7,8-dihydro-2’-deoxyguanosine by isotope-dilution liquid chromatography-tandem mass spectrometry with on-line solid-phase extraction. Clin. Chem. 52, 1381–1388.
Weimann, A., Belling, D., and Poulsen, H.E. (2001) Measurement of 8-oxo-2’-deoxyguanosine and 8-oxo-2’-deoxyadenosine in DNA and human urine by high performance liquid chromatography-electrospray tandem mass spectrometry. Free Radic. Biol. Med. 30, 757–764.
Lin, H.S., Jenner, A.M., Ong, C.N., Huang, S.H., Whiteman, M., and Halliwell, B. (2004) A high-throughput and sensitive methodology for the quantification of urinary 8-hydroxy-2’-deoxyguanosine: measurement with gas chromatography–mass spectrometry after single solid-phase extraction. Biochem. J. 380, 541–548.
Cooke, M.S., Singh, R., Hall, G.K., Mistry, V., Duarte, T.L., Farmer, P.B., and Evans, M.D. (2006) Evaluation of enzyme-linked immunosorbent assay and liquid chromatography-tandem mass spectrometry methodology for the analysis of 8-oxo-7,8-dihydro-2’-deoxyguanosine in saliva and urine. Free Radic. Biol. Med. 41, 1829–1836.
Singh, R., McEwan, M., Lamb, J.H., Santella, R.M., and Farmer, P.B. (2003) An improved liquid chromatography/tandem mass spectrometry method for the determination of 8-oxo-7,8-dihydro-2’-deoxyguanosine in DNA samples using immunoaffinity column purification. Rapid Commun. Mass Spectrum. 17, 126–134.
Loft, S., Svoboda, P., Kasai, H., Tjonneland, A., Vogel, U., Moller, P., Overvad, K., and Raaschou-Nielsen, O. (2006). Prospective study of 8-oxo-7,8-dihydro-2’-deoxyguanosine excretion and the risk of lung cancer. Carcinogenesis 27, 1245–1250.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2010 Humana Press, a part of Springer Science+Business Media, LLC
About this protocol
Cite this protocol
Evans, M.D., Singh, R., Mistry, V., Farmer, P.B., Cooke, M.S. (2010). Analysis of Urinary 8-oxo-7,8-dihydro-2′-deoxyguanosine by Liquid Chromatography–Tandem Mass Spectrometry. In: Uppu, R., Murthy, S., Pryor, W., Parinandi, N. (eds) Free Radicals and Antioxidant Protocols. Methods in Molecular Biology, vol 610. Humana Press. https://doi.org/10.1007/978-1-60327-029-8_20
Download citation
DOI: https://doi.org/10.1007/978-1-60327-029-8_20
Published:
Publisher Name: Humana Press
Print ISBN: 978-1-58829-710-5
Online ISBN: 978-1-60327-029-8
eBook Packages: Springer Protocols